APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vulvar and Vaginal Atrophy Therapy

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Vulvar and Vaginal Atrophy Therapy Industry Growth and Trends Forecast to 2032

31 December 202591 pages

Choose your research edition.

Industry ResearchVulvar and Vaginal Atrophy Therapy Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Vulvar and Vaginal Atrophy Therapy Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Vulvar and Vaginal Atrophy Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vulvar and Vaginal Atrophy Therapy Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Vulvar and Vaginal Atrophy Therapy Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Vulvar and Vaginal Atrophy Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Vulvar and Vaginal Atrophy Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Vulvar and Vaginal Atrophy Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vulvar and Vaginal Atrophy Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Vulvar and Vaginal Atrophy Therapy include Viveve, VenusConcept, ThermiGen LLC, Lutronic, Hologic, Fotona, BTL Group of Companies, Almirall and Alma Lasers, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Vulvar and Vaginal Atrophy Therapy market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Vulvar and Vaginal Atrophy Therapy market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Vulvar and Vaginal Atrophy Therapy market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Vulvar and Vaginal Atrophy Therapy.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Vulvar and Vaginal Atrophy Therapy market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Vulvar and Vaginal Atrophy Therapy Market by Company

Viveve

VenusConcept

ThermiGen LLC

Lutronic

Hologic

Fotona

BTL Group of Companies

Almirall

Alma Lasers

Vulvar and Vaginal Atrophy Therapy Segment by Type

Vulvar Atrophy Therapy

Vaginal Atrophy Therapy

Vulvar and Vaginal Atrophy Therapy Segment by Application

Specialty Clinics

Hospitals

Ambulatory Surgical Centers

Others

Vulvar and Vaginal Atrophy Therapy Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vulvar and Vaginal Atrophy Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vulvar and Vaginal Atrophy Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vulvar and Vaginal Atrophy Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Vulvar and Vaginal Atrophy Therapy manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Vulvar and Vaginal Atrophy Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Vulvar Atrophy Therapy Table 2. Major Company of Vaginal Atrophy Therapy Table 3. Global Vulvar and Vaginal Atrophy Therapy Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Vulvar and Vaginal Atrophy Therapy Sales by Type (2021-2026) & (K Units) Table 5. Global Vulvar and Vaginal Atrophy Therapy Sales Market Share in Volume by Type (2021-2026) Table 6. Global Vulvar and Vaginal Atrophy Therapy Sales by Type (2021-2026) & (US$ Million) Table 7. Global Vulvar and Vaginal Atrophy Therapy Sales Market Share in Value by Type (2021-2026) Table 8. Global Vulvar and Vaginal Atrophy Therapy Price by Type (2021-2026) & (US$/Unit) Table 9. Global Vulvar and Vaginal Atrophy Therapy Sales by Type (2027-2032) & (K Units) Table 10. Global Vulvar and Vaginal Atrophy Therapy Sales Market Share in Volume by Type (2027-2032) Table 11. Global Vulvar and Vaginal Atrophy Therapy Sales by Type (2027-2032) & (US$ Million) Table 12. Global Vulvar and Vaginal Atrophy Therapy Sales Market Share in Value by Type (2027-2032) Table 13. Global Vulvar and Vaginal Atrophy Therapy Price by Type (2027-2032) & (US$/Unit) Table 14. North America Vulvar and Vaginal Atrophy Therapy Sales by Type (2021-2026) & (K Units) Table 15. North America Vulvar and Vaginal Atrophy Therapy Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Vulvar and Vaginal Atrophy Therapy Sales by Type (2021-2026) & (K Units) Table 17. Europe Vulvar and Vaginal Atrophy Therapy Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Vulvar and Vaginal Atrophy Therapy Sales by Type (2021-2026) & (K Units) Table 21. Latin America Vulvar and Vaginal Atrophy Therapy Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Vulvar and Vaginal Atrophy Therapy Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Vulvar and Vaginal Atrophy Therapy Sales by Type (2021-2026) & (US$ Million) Table 24. Vulvar and Vaginal Atrophy Therapy Industry Trends Table 25. Vulvar and Vaginal Atrophy Therapy Industry Drivers Table 26. Vulvar and Vaginal Atrophy Therapy Industry Opportunities and Challenges Table 27. Vulvar and Vaginal Atrophy Therapy Industry Restraints Table 28. Global Vulvar and Vaginal Atrophy Therapy Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Company (2021-2026) Table 30. Global Vulvar and Vaginal Atrophy Therapy Sales by Company (2021-2026) & (K Units) Table 31. Global Vulvar and Vaginal Atrophy Therapy Sales Share by Company (2021-2026) Table 32. Global Vulvar and Vaginal Atrophy Therapy Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Vulvar and Vaginal Atrophy Therapy Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Vulvar and Vaginal Atrophy Therapy Major Company Production Sites and Headquarters Table 35. Global Vulvar and Vaginal Atrophy Therapy Company, Product Type & Application Table 36. Global Vulvar and Vaginal Atrophy Therapy Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Vulvar and Vaginal Atrophy Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Vulvar and Vaginal Atrophy Therapy Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Vulvar and Vaginal Atrophy Therapy Sales by Region (2021-2026) & (K Units) Table 41. Global Vulvar and Vaginal Atrophy Therapy Sales Market Share in Volume by Region (2021-2026) Table 42. Global Vulvar and Vaginal Atrophy Therapy Sales by Region (2021-2026) & (US$ Million) Table 43. Global Vulvar and Vaginal Atrophy Therapy Sales Market Share in Value by Region (2021-2026) Table 44. Global Vulvar and Vaginal Atrophy Therapy Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Vulvar and Vaginal Atrophy Therapy Sales by Region (2027-2032) & (K Units) Table 46. Global Vulvar and Vaginal Atrophy Therapy Sales Market Share in Volume by Region (2027-2032) Table 47. Global Vulvar and Vaginal Atrophy Therapy Sales by Region (2027-2032) & (US$ Million) Table 48. Global Vulvar and Vaginal Atrophy Therapy Sales Market Share in Value by Region (2027-2032) Table 49. Global Vulvar and Vaginal Atrophy Therapy Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Vulvar and Vaginal Atrophy Therapy Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Vulvar and Vaginal Atrophy Therapy Sales by Application (2021-2026) & (K Units) Table 52. Global Vulvar and Vaginal Atrophy Therapy Sales Market Share in Volume by Application (2021-2026) Table 53. Global Vulvar and Vaginal Atrophy Therapy Sales by Application (2021-2026) & (US$ Million) Table 54. Global Vulvar and Vaginal Atrophy Therapy Sales Market Share in Value by Application (2021-2026) Table 55. Global Vulvar and Vaginal Atrophy Therapy Price by Application (2021-2026) & (US$/Unit) Table 56. Global Vulvar and Vaginal Atrophy Therapy Sales by Application (2027-2032) & (K Units) Table 57. Global Vulvar and Vaginal Atrophy Therapy Sales Market Share in Volume by Application (2027-2032) Table 58. Global Vulvar and Vaginal Atrophy Therapy Sales by Application (2027-2032) & (US$ Million) Table 59. Global Vulvar and Vaginal Atrophy Therapy Sales Market Share in Value by Application (2027-2032) Table 60. Global Vulvar and Vaginal Atrophy Therapy Price by Application (2027-2032) & (US$/Unit) Table 61. North America Vulvar and Vaginal Atrophy Therapy Sales by Application (2021-2026) & (K Units) Table 62. North America Vulvar and Vaginal Atrophy Therapy Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Vulvar and Vaginal Atrophy Therapy Sales by Application (2021-2026) & (K Units) Table 64. Europe Vulvar and Vaginal Atrophy Therapy Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Vulvar and Vaginal Atrophy Therapy Sales by Application (2021-2026) & (K Units) Table 68. Latin America Vulvar and Vaginal Atrophy Therapy Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Vulvar and Vaginal Atrophy Therapy Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Vulvar and Vaginal Atrophy Therapy Sales by Application (2021-2026) & (US$ Million) Table 71. Viveve Company Information Table 72. Viveve Business Overview Table 73. Viveve Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Viveve Vulvar and Vaginal Atrophy Therapy Product Portfolio Table 75. Viveve Recent Development Table 76. VenusConcept Company Information Table 77. VenusConcept Business Overview Table 78. VenusConcept Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. VenusConcept Vulvar and Vaginal Atrophy Therapy Product Portfolio Table 80. VenusConcept Recent Development Table 81. ThermiGen LLC Company Information Table 82. ThermiGen LLC Business Overview Table 83. ThermiGen LLC Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. ThermiGen LLC Vulvar and Vaginal Atrophy Therapy Product Portfolio Table 85. ThermiGen LLC Recent Development Table 86. Lutronic Company Information Table 87. Lutronic Business Overview Table 88. Lutronic Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Lutronic Vulvar and Vaginal Atrophy Therapy Product Portfolio Table 90. Lutronic Recent Development Table 91. Hologic Company Information Table 92. Hologic Business Overview Table 93. Hologic Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Hologic Vulvar and Vaginal Atrophy Therapy Product Portfolio Table 95. Hologic Recent Development Table 96. Fotona Company Information Table 97. Fotona Business Overview Table 98. Fotona Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Fotona Vulvar and Vaginal Atrophy Therapy Product Portfolio Table 100. Fotona Recent Development Table 101. BTL Group of Companies Company Information Table 102. BTL Group of Companies Business Overview Table 103. BTL Group of Companies Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. BTL Group of Companies Vulvar and Vaginal Atrophy Therapy Product Portfolio Table 105. BTL Group of Companies Recent Development Table 106. Almirall Company Information Table 107. Almirall Business Overview Table 108. Almirall Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Almirall Vulvar and Vaginal Atrophy Therapy Product Portfolio Table 110. Almirall Recent Development Table 111. Alma Lasers Company Information Table 112. Alma Lasers Business Overview Table 113. Alma Lasers Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Alma Lasers Vulvar and Vaginal Atrophy Therapy Product Portfolio Table 115. Alma Lasers Recent Development Table 116. North America Vulvar and Vaginal Atrophy Therapy Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. North America Vulvar and Vaginal Atrophy Therapy Sales by Country (2021-2026) & (K Units) Table 118. North America Vulvar and Vaginal Atrophy Therapy Sales Market Share by Country (2021-2026) Table 119. North America Vulvar and Vaginal Atrophy Therapy Sales Forecast by Country (2027-2032) & (K Units) Table 120. North America Vulvar and Vaginal Atrophy Therapy Sales Market Share Forecast by Country (2027-2032) Table 121. North America Vulvar and Vaginal Atrophy Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Vulvar and Vaginal Atrophy Therapy Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Vulvar and Vaginal Atrophy Therapy Market Share by Country (2021-2026) Table 124. North America Vulvar and Vaginal Atrophy Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Vulvar and Vaginal Atrophy Therapy Market Share Forecast by Country (2027-2032) Table 126. Europe Vulvar and Vaginal Atrophy Therapy Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Europe Vulvar and Vaginal Atrophy Therapy Sales by Country (2021-2026) & (K Units) Table 128. Europe Vulvar and Vaginal Atrophy Therapy Sales Market Share by Country (2021-2026) Table 129. Europe Vulvar and Vaginal Atrophy Therapy Sales Forecast by Country (2027-2032) & (K Units) Table 130. Europe Vulvar and Vaginal Atrophy Therapy Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Vulvar and Vaginal Atrophy Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Vulvar and Vaginal Atrophy Therapy Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Vulvar and Vaginal Atrophy Therapy Market Share by Country (2021-2026) Table 134. Europe Vulvar and Vaginal Atrophy Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Vulvar and Vaginal Atrophy Therapy Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales by Country (2021-2026) & (K Units) Table 138. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales Forecast by Country (2027-2032) & (K Units) Table 140. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Market Share by Country (2021-2026) Table 144. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Market Share Forecast by Country (2027-2032) Table 146. Latin America Vulvar and Vaginal Atrophy Therapy Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Latin America Vulvar and Vaginal Atrophy Therapy Sales by Country (2021-2026) & (K Units) Table 148. Latin America Vulvar and Vaginal Atrophy Therapy Sales Market Share by Country (2021-2026) Table 149. Latin America Vulvar and Vaginal Atrophy Therapy Sales Forecast by Country (2027-2032) & (K Units) Table 150. Latin America Vulvar and Vaginal Atrophy Therapy Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Vulvar and Vaginal Atrophy Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Vulvar and Vaginal Atrophy Therapy Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Vulvar and Vaginal Atrophy Therapy Market Share by Country (2021-2026) Table 154. Latin America Vulvar and Vaginal Atrophy Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Vulvar and Vaginal Atrophy Therapy Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Vulvar and Vaginal Atrophy Therapy Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Vulvar and Vaginal Atrophy Therapy Sales by Country (2021-2026) & (K Units) Table 158. Middle East and Africa Vulvar and Vaginal Atrophy Therapy Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Vulvar and Vaginal Atrophy Therapy Sales Forecast by Country (2027-2032) & (K Units) Table 160. Middle East and Africa Vulvar and Vaginal Atrophy Therapy Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Vulvar and Vaginal Atrophy Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Vulvar and Vaginal Atrophy Therapy Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Vulvar and Vaginal Atrophy Therapy Market Share by Country (2021-2026) Table 164. Middle East and Africa Vulvar and Vaginal Atrophy Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Vulvar and Vaginal Atrophy Therapy Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Vulvar and Vaginal Atrophy Therapy Distributors List Table 169. Vulvar and Vaginal Atrophy Therapy Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Vulvar and Vaginal Atrophy Therapy Image Figure 2. Global Vulvar and Vaginal Atrophy Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vulvar and Vaginal Atrophy Therapy Market Size (2021-2032) & (US$ Million) Figure 4. Global Vulvar and Vaginal Atrophy Therapy Sales (2021-2032) & (K Units) Figure 5. Vulvar Atrophy Therapy Image Figure 6. Global Vulvar Atrophy Therapy Sales YoY Growth (2021-2032) & (K Units) Figure 7. Vaginal Atrophy Therapy Image Figure 8. Global Vaginal Atrophy Therapy Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Vulvar and Vaginal Atrophy Therapy Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Vulvar and Vaginal Atrophy Therapy Market Share by Type 2025 VS 2032 Figure 11. North America Vulvar and Vaginal Atrophy Therapy Sales Market Share in Volume by Type in 2025 Figure 12. North America Vulvar and Vaginal Atrophy Therapy Sales Market Share in Value by Type in 2025 Figure 13. Europe Vulvar and Vaginal Atrophy Therapy Sales Market Share in Volume by Type in 2025 Figure 14. Europe Vulvar and Vaginal Atrophy Therapy Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales Market Share in Value by Type in 2025 Figure 17. Latin America Vulvar and Vaginal Atrophy Therapy Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Vulvar and Vaginal Atrophy Therapy Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Vulvar and Vaginal Atrophy Therapy Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Vulvar and Vaginal Atrophy Therapy Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Vulvar and Vaginal Atrophy Therapy Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Specialty Clinics Image Figure 24. Global Specialty Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 25. Hospitals Image Figure 26. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 27. Ambulatory Surgical Centers Image Figure 28. Global Ambulatory Surgical Centers Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Vulvar and Vaginal Atrophy Therapy Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Vulvar and Vaginal Atrophy Therapy Market Share by Application 2025 VS 2032 Figure 33. North America Vulvar and Vaginal Atrophy Therapy Sales Market Share in Volume by Application in 2025 Figure 34. North America Vulvar and Vaginal Atrophy Therapy Sales Market Share in Value by Application in 2025 Figure 35. Europe Vulvar and Vaginal Atrophy Therapy Sales Market Share in Volume by Application in 2025 Figure 36. Europe Vulvar and Vaginal Atrophy Therapy Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales Market Share in Value by Application in 2025 Figure 39. Latin America Vulvar and Vaginal Atrophy Therapy Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Vulvar and Vaginal Atrophy Therapy Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Vulvar and Vaginal Atrophy Therapy Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Vulvar and Vaginal Atrophy Therapy Sales Market Share in Value by Application in 2025 Figure 43. North America Vulvar and Vaginal Atrophy Therapy Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Vulvar and Vaginal Atrophy Therapy Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Vulvar and Vaginal Atrophy Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Vulvar and Vaginal Atrophy Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Vulvar and Vaginal Atrophy Therapy Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Vulvar and Vaginal Atrophy Therapy Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Vulvar and Vaginal Atrophy Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Vulvar and Vaginal Atrophy Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Vulvar and Vaginal Atrophy Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Vulvar and Vaginal Atrophy Therapy Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Vulvar and Vaginal Atrophy Therapy Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Vulvar and Vaginal Atrophy Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Vulvar and Vaginal Atrophy Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Vulvar and Vaginal Atrophy Therapy Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Vulvar and Vaginal Atrophy Therapy Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Vulvar and Vaginal Atrophy Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Vulvar and Vaginal Atrophy Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Vulvar and Vaginal Atrophy Therapy Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Vulvar and Vaginal Atrophy Therapy Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Vulvar Atrophy Therapy
  • Vaginal Atrophy Therapy
Applications
  • Specialty Clinics
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
Companies covered
  • Viveve
  • VenusConcept
  • ThermiGen LLC
  • Lutronic
  • Hologic
  • Fotona
  • BTL Group of Companies
  • Almirall
  • Alma Lasers

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Vulvar and Vaginal Atrophy Therapy Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Vulvar and Vaginal Atrophy Therapy Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Vulvar and Vaginal Atrophy Therapy Market by Type
  6. 1.3.1 Vulvar Atrophy Therapy
  7. 1.3.2 Vaginal Atrophy Therapy
  8. 1.4 Global Vulvar and Vaginal Atrophy Therapy Market Size by Type
  9. 1.4.1 Global Vulvar and Vaginal Atrophy Therapy Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Vulvar and Vaginal Atrophy Therapy Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Vulvar and Vaginal Atrophy Therapy Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Vulvar and Vaginal Atrophy Therapy Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Vulvar and Vaginal Atrophy Therapy Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Vulvar and Vaginal Atrophy Therapy Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Vulvar and Vaginal Atrophy Therapy Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Vulvar and Vaginal Atrophy Therapy Industry Trends
  2. 2.2 Vulvar and Vaginal Atrophy Therapy Industry Drivers
  3. 2.3 Vulvar and Vaginal Atrophy Therapy Industry Opportunities and Challenges
  4. 2.4 Vulvar and Vaginal Atrophy Therapy Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Vulvar and Vaginal Atrophy Therapy Revenue (2021-2026)
  2. 3.2 Global Top Players by Vulvar and Vaginal Atrophy Therapy Sales (2021-2026)
  3. 3.3 Global Top Players by Vulvar and Vaginal Atrophy Therapy Price (2021-2026)
  4. 3.4 Global Vulvar and Vaginal Atrophy Therapy Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Vulvar and Vaginal Atrophy Therapy Major Company Production Sites & Headquarters
  6. 3.6 Global Vulvar and Vaginal Atrophy Therapy Company, Product Type & Application
  7. 3.7 Global Vulvar and Vaginal Atrophy Therapy Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Vulvar and Vaginal Atrophy Therapy Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Vulvar and Vaginal Atrophy Therapy Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Vulvar and Vaginal Atrophy Therapy Tier 1, Tier 2, and Tier 3
4 Vulvar and Vaginal Atrophy Therapy Regional Status and Outlook
  1. 4.1 Global Vulvar and Vaginal Atrophy Therapy Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Vulvar and Vaginal Atrophy Therapy Historic Market Size by Region
  3. 4.2.1 Global Vulvar and Vaginal Atrophy Therapy Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Vulvar and Vaginal Atrophy Therapy Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Vulvar and Vaginal Atrophy Therapy Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Vulvar and Vaginal Atrophy Therapy Forecasted Market Size by Region
  7. 4.3.1 Global Vulvar and Vaginal Atrophy Therapy Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Vulvar and Vaginal Atrophy Therapy Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Vulvar and Vaginal Atrophy Therapy Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Vulvar and Vaginal Atrophy Therapy by Application
  1. 5.1 Vulvar and Vaginal Atrophy Therapy Market by Application
  2. 5.1.1 Specialty Clinics
  3. 5.1.2 Hospitals
  4. 5.1.3 Ambulatory Surgical Centers
  5. 5.1.4 Others
  6. 5.2 Global Vulvar and Vaginal Atrophy Therapy Market Size by Application
  7. 5.2.1 Global Vulvar and Vaginal Atrophy Therapy Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Vulvar and Vaginal Atrophy Therapy Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Vulvar and Vaginal Atrophy Therapy Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Vulvar and Vaginal Atrophy Therapy Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Vulvar and Vaginal Atrophy Therapy Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Vulvar and Vaginal Atrophy Therapy Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Vulvar and Vaginal Atrophy Therapy Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Viveve
  2. 6.1.1 Viveve Company Information
  3. 6.1.2 Viveve Business Overview
  4. 6.1.3 Viveve Vulvar and Vaginal Atrophy Therapy Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Viveve Vulvar and Vaginal Atrophy Therapy Product Portfolio
  6. 6.1.5 Viveve Recent Developments
  7. 6.2 VenusConcept
  8. 6.2.1 VenusConcept Company Information
  9. 6.2.2 VenusConcept Business Overview
  10. 6.2.3 VenusConcept Vulvar and Vaginal Atrophy Therapy Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 VenusConcept Vulvar and Vaginal Atrophy Therapy Product Portfolio
  12. 6.2.5 VenusConcept Recent Developments
  13. 6.3 ThermiGen LLC
  14. 6.3.1 ThermiGen LLC Company Information
  15. 6.3.2 ThermiGen LLC Business Overview
  16. 6.3.3 ThermiGen LLC Vulvar and Vaginal Atrophy Therapy Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 ThermiGen LLC Vulvar and Vaginal Atrophy Therapy Product Portfolio
  18. 6.3.5 ThermiGen LLC Recent Developments
  19. 6.4 Lutronic
  20. 6.4.1 Lutronic Company Information
  21. 6.4.2 Lutronic Business Overview
  22. 6.4.3 Lutronic Vulvar and Vaginal Atrophy Therapy Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Lutronic Vulvar and Vaginal Atrophy Therapy Product Portfolio
  24. 6.4.5 Lutronic Recent Developments
  25. 6.5 Hologic
  26. 6.5.1 Hologic Company Information
  27. 6.5.2 Hologic Business Overview
  28. 6.5.3 Hologic Vulvar and Vaginal Atrophy Therapy Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hologic Vulvar and Vaginal Atrophy Therapy Product Portfolio
  30. 6.5.5 Hologic Recent Developments
  31. 6.6 Fotona
  32. 6.6.1 Fotona Company Information
  33. 6.6.2 Fotona Business Overview
  34. 6.6.3 Fotona Vulvar and Vaginal Atrophy Therapy Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Fotona Vulvar and Vaginal Atrophy Therapy Product Portfolio
  36. 6.6.5 Fotona Recent Developments
  37. 6.7 BTL Group of Companies
  38. 6.7.1 BTL Group of Companies Company Information
  39. 6.7.2 BTL Group of Companies Business Overview
  40. 6.7.3 BTL Group of Companies Vulvar and Vaginal Atrophy Therapy Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 BTL Group of Companies Vulvar and Vaginal Atrophy Therapy Product Portfolio
  42. 6.7.5 BTL Group of Companies Recent Developments
  43. 6.8 Almirall
  44. 6.8.1 Almirall Company Information
  45. 6.8.2 Almirall Business Overview
  46. 6.8.3 Almirall Vulvar and Vaginal Atrophy Therapy Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Almirall Vulvar and Vaginal Atrophy Therapy Product Portfolio
  48. 6.8.5 Almirall Recent Developments
  49. 6.9 Alma Lasers
  50. 6.9.1 Alma Lasers Company Information
  51. 6.9.2 Alma Lasers Business Overview
  52. 6.9.3 Alma Lasers Vulvar and Vaginal Atrophy Therapy Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Alma Lasers Vulvar and Vaginal Atrophy Therapy Product Portfolio
  54. 6.9.5 Alma Lasers Recent Developments
7 North America by Country
  1. 7.1 North America Vulvar and Vaginal Atrophy Therapy Sales by Country
  2. 7.1.1 North America Vulvar and Vaginal Atrophy Therapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Vulvar and Vaginal Atrophy Therapy Sales by Country (2021-2026)
  4. 7.1.3 North America Vulvar and Vaginal Atrophy Therapy Sales Forecast by Country (2027-2032)
  5. 7.2 North America Vulvar and Vaginal Atrophy Therapy Market Size by Country
  6. 7.2.1 North America Vulvar and Vaginal Atrophy Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Vulvar and Vaginal Atrophy Therapy Market Size by Country (2021-2026)
  8. 7.2.3 North America Vulvar and Vaginal Atrophy Therapy Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Vulvar and Vaginal Atrophy Therapy Sales by Country
  2. 8.1.1 Europe Vulvar and Vaginal Atrophy Therapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Vulvar and Vaginal Atrophy Therapy Sales by Country (2021-2026)
  4. 8.1.3 Europe Vulvar and Vaginal Atrophy Therapy Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Vulvar and Vaginal Atrophy Therapy Market Size by Country
  6. 8.2.1 Europe Vulvar and Vaginal Atrophy Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Vulvar and Vaginal Atrophy Therapy Market Size by Country (2021-2026)
  8. 8.2.3 Europe Vulvar and Vaginal Atrophy Therapy Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales by Country
  2. 9.1.1 Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Vulvar and Vaginal Atrophy Therapy Market Size by Country
  6. 9.2.1 Asia-Pacific Vulvar and Vaginal Atrophy Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Vulvar and Vaginal Atrophy Therapy Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Vulvar and Vaginal Atrophy Therapy Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Vulvar and Vaginal Atrophy Therapy Sales by Country
  2. 10.1.1 South America Vulvar and Vaginal Atrophy Therapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Vulvar and Vaginal Atrophy Therapy Sales by Country (2021-2026)
  4. 10.1.3 South America Vulvar and Vaginal Atrophy Therapy Sales Forecast by Country (2027-2032)
  5. 10.2 South America Vulvar and Vaginal Atrophy Therapy Market Size by Country
  6. 10.2.1 South America Vulvar and Vaginal Atrophy Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Vulvar and Vaginal Atrophy Therapy Market Size by Country (2021-2026)
  8. 10.2.3 South America Vulvar and Vaginal Atrophy Therapy Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Vulvar and Vaginal Atrophy Therapy Sales by Country
  2. 11.1.1 Middle East and Africa Vulvar and Vaginal Atrophy Therapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Vulvar and Vaginal Atrophy Therapy Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Vulvar and Vaginal Atrophy Therapy Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Vulvar and Vaginal Atrophy Therapy Market Size by Country
  6. 11.2.1 Middle East and Africa Vulvar and Vaginal Atrophy Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Vulvar and Vaginal Atrophy Therapy Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Vulvar and Vaginal Atrophy Therapy Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Vulvar and Vaginal Atrophy Therapy Value Chain Analysis
  2. 12.1.1 Vulvar and Vaginal Atrophy Therapy Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Vulvar and Vaginal Atrophy Therapy Production Mode & Process
  7. 12.2 Vulvar and Vaginal Atrophy Therapy Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Vulvar and Vaginal Atrophy Therapy Distributors
  10. 12.2.3 Vulvar and Vaginal Atrophy Therapy Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst